Two Years Later: Is What I Told the Wall Street Journal About Psychedelics Still True?
Two years after my Wall Street Journal quote on psychedelic risks, the hype is giving way to nuance. This article explores what’s happened since, emerging research on ketamine’s risks for trauma survivors, and why trauma-informed care is essential as psychedelic therapy moves forward.
Dopamine and Depth Psychology: The Long Cycle of Addiction Hiding in Plain Sight
My key observation over my 10 years of watching people move through levels of addiction care was the progression of relapse, and how it often wasn’t a straight line back to substance use. It typically took a detour first into something Freud called “repetition compulsion.”